Home > Healthcare > Medical Devices > Diagnostic Devices > at home drug of abuse testing market
Get a free sample of At-home Drug of Abuse (DOA) Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of At-home Drug of Abuse (DOA) Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some of the eminent market participants operating in the at-home drug of abuse testing market include :
These participants are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
The global market for at-home drug of abuse testing was reached USD 3.5 billion in 2022 and is estimated to account for USD 7.2 billion by 2032, as it allows individuals to conduct drug tests in the privacy of their own homes.
The test strips segment garnered USD 1.7 billion in the year 2022, as it offers quick and straightforward drug testing procedures, providing convenience to individuals.
U.S. at-home drug of abuse testing market exceeded USD 1.2 billion in 2022 and is predicted to witness substantial growth through 2032, owing to high prevalence of drug abuse and substance use disorders in the country.
Confirm BioSciences, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., bioM